溶血磷脂酸及脂蛋白相关性磷脂酶A2与缺血性心脑血管病

被引:5
作者
李振光
鞠卫萍
王远臣
机构
[1] 潍坊医学院附属文登中心医院神经内科
关键词
溶血磷脂酸; 磷脂酶A; 卒中; 预防;
D O I
暂无
中图分类号
R54 [心脏、血管(循环系)疾病]; R743.3 [急性脑血管疾病(中风)];
学科分类号
1002 ; 100201 ;
摘要
<正>溶血磷脂酸(lysophosphatidic acid,LPA)及脂蛋白相关性磷脂酶A2(lipoprotein-associated phospholipase A2,Lp-PLA2)是近年来被广泛关注的与动脉粥样硬化和缺血性心脑血管病密切相关的分子家族,特别是它们在启动动脉粥样硬化与缺血性心脑血管病中的重要作用及潜在的临床应用价值引起人们的极大关注
引用
收藏
页码:834 / 840
页数:7
相关论文
共 17 条
[1]   短暂性脑缺血发作患者血浆溶血磷脂酸含量变化及阿司匹林对其的影响 [J].
李振光 ;
伍期专 ;
于占彩 ;
王远臣 ;
姚存姗 .
中华老年心脑血管病杂志, 2005, (02) :109-111
[2]   溶血磷脂酸在动脉粥样硬化和缺血性心脑血管病中的作用 [J].
李振光 ;
于占彩 ;
伍期专 .
国外医学(脑血管疾病分册), 2004, (12) :928-932
[3]   动脉粥样硬化患者颈动脉内膜中层厚度与血浆溶血磷脂酸含量的变化 [J].
李振光 ;
伍期专 ;
唐朝枢 ;
于占彩 ;
王远臣 ;
姚存姗 ;
周慧杰 ;
杨素国 ;
于战涛 .
中华医学杂志, 2004, (13) :19-20
[4]   脂蛋白相关性磷脂酶A2与缺血性心脑血管病 [J].
李振光 ;
于占彩 ;
王远臣 .
国际脑血管病杂志, 2007, (02) :102-105
[5]   Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target [J].
Macphee, CH ;
Nelson, J ;
Zalewski, A .
CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (02) :154-161
[6]  
Lipoprotein-Associated Phospholipase A2 and Its Association With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction) Trial[J] . Michelle O’Donoghue,David A. Morrow,Marc S. Sabatine,Sabina A. Murphy,Carolyn H. McCabe,Christopher P. Cannon,Eugene Braunwald.Circulation . 2006 (14)
[7]  
Association between Lp-PLA 2 and coronary artery disease: Focus on its relationship with lipoproteins and markers of inflammation and hemostasis[J] . Natalie Khuseyinova,Armin Imhof,Dietrich Rothenbacher,Gerlinde Trischler,Silke Kuelb,Hubert Scharnagl,Winfried Maerz,Hermann Brenner,Wolfgang Koenig.Atherosclerosis . 2005 (1)
[8]  
Lipoprotein-Associated Phospholipase A2 Activity Is Associated With Risk of Coronary Heart Disease and Ischemic Stroke: The Rotterdam Study[J] . Hok-Hay S. Oei,Irene M. van der Meer,Albert Hofman,Peter J. Koudstaal,Theo Stijnen,Monique M.B. Breteler,Jacqueline C.M. Witteman.Circulation . 2005 (5)
[9]  
Lipoprotein-Associated Phospholipase A2 Adds to Risk Prediction of Incident Coronary Events by C-Reactive Protein in Apparently Healthy Middle-Aged Men From the General Population: Results From the 14-Year Follow-Up of a Large Cohort From Southern Germany[J] . Circulation . 2004 (14)
[10]  
Lipoprotein-Associated Phospholipase A2, High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study[J] . Christie M. Ballantyne,Ron C. Hoogeveen,Heejung Bang,Josef Coresh,Aaron R. Folsom,Gerardo Heiss,A. Richey Sharrett.Circulation: Journal of the American Heart Association . 2004 (7)